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Issue Brief

How Does Quality
Enter into Health Care
Purchasing Decisions?
Neil I. Goldfarb,Vittorio Maio, Chureen T. Carter,
Laura Pizzi, and David B. Nash*
The Commonwealth Fund is a
private foundation supporting
independent research on health
and social issues. The views presented here are those of the authors
and should not be attributed to
The Commonwealth Fund or its
directors, officers, or staff.
For more information,
please contact:

A

number of employers, business consortia, and public purchasers
are promoting “value-based purchasing” as a way to improve the
quality of patient care. Some purchasers are using publicly available information on health plan and provider performance to make their
health plan and provider choices, while others are using their market
power to drive improvements in patient care and safety. From a review we
conducted of published literature on value-based purchasing, six key strategies used by purchasers emerge:1
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6. Rewarding or penalizing through incentives or disincentives.
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Although it appears that a number of purchasers are beginning to initiate or join valuebased purchasing efforts, the majority of purchasers
are not active participants. Moreover, there is little
evidence to date that these activities are achieving
a real impact. This issue brief, which is based on
interviews with selected experts in the field, examines the extent of current value-based purchasing
efforts and identifies the key obstacles to achieving
broader engagement and greater impact, from the
basic lack of a “quality-improvement culture” to
more tangible barriers, including inadequate plan
and physician performance data.2
While purchasers, particularly large employers, have yet to exercise fully their market power to
demand better health care, many observers believe
that they are precisely the group that is most likely
to bring about measurable improvements down the
road. Finding ways, then, to foster their role in
raising the quality of care is crucial to the success
of value-based purchasing as a viable model.
VALUE-BASED PURCHASING: FINDINGS
FROM A SURVEY
To learn more about existing value-based purchasing (VBP) programs, find successful models, and
identify the factors helping and hindering their
success, we conducted a telephone survey of
experts involved in some way with the VBP movement. Fifty-seven individuals took part in the survey, including 16 employers, 11 executives from
insurance companies and health plans, 10 officials
with support organizations (e.g., professional societies, consumer and industry advocate groups, and
think tanks), seven federal and state government
workers, seven academic researchers, and six health
care consultants.
Model Value-Based Purchasing Programs
Participants were asked to provide examples of
successful VBP programs: they named six business
consortia and 12 individual employers.3 While the
examples do not comprise a complete or representative sample of VBP programs nationwide, they
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did provide a context for the discussions. In a second phase of research, we will investigate existing
VBP programs and identify successful program
components.
The experts we interviewed pointed to the
following factors that contribute to the success of
these programs:
●

●

●

●

●

●

●

●

●

Leadership’s commitment to pursuing VBP as
a long-term strategy, including investment of
human and financial resources.
Availability and credibility of data to guide
identification of better quality and monitor
impact of quality improvement interventions.
Availability of accurate and reliable measures
of quality.
Provider and other key stakeholder involvement in planning VBP activities.
Incorporation of performance measurement
on a provider level, and development of nonpunitive feedback mechanisms.
Use of financial incentives (e.g., bonus payments) to drive quality.
Development of strategies to educate consumers and empower them to select higherquality health plans and providers.
Having sufficient local and regional purchasing
power to garner the attention and cooperation
of health plans and providers.
Creation of a corporate culture that makes
quality a priority across the entire organization.

Barriers to Value-Based Purchasing
Respondents identified a range of barriers that
prevent purchasers from engaging in VBP activities, including problems with incentives, leadership,
and data availability. Specific barriers are listed
below by category.
General Barriers
●

Lack of consensus on what constitutes quality
of care.

How Does Quality Enter into Health Insurance Purchasing Decisions?

●

●

●

●

●

●

Lack of an organization-wide culture in which
quality is viewed as an important strategic policy.
Lack of a business case for quality improvement—i.e., evidence that investments in quality will yield economic rewards.
Lack of a forum for talking about quality.
Legislative and political limitations, such as
issues related to the Health Insurance
Portability and Accountability Act (HIPAA),
which could restrict access to data needed to
monitor quality and the impact of quality
improvement measures.
Lack of leadership.
Lack of communication among stakeholders—
e.g., between purchasers and insurers and
between health plans and participating doctors.

Barriers Related to Quality-of-Care Data
●

●

●

Limited availability of data.
Burden associated with collecting or obtaining
data.
Generally poor quality of data, including insufficient level of detail (e.g., physician information) and lack of timeliness.

Barriers Related to Quality Measurement
●

●

●

●

Lack of agreement on standardized performance measures.
Difficulty in interpreting existing performance
measures (e.g., what they actually measure;
what the expected level of performance is;
how important any one measure is in relation
to others).
Lack of consistency in findings across multiple
measures.
Measures focused on care processes rather than
patient outcomes.

In addition, the experts we interviewed
identified barriers to growth in value-based purchasing that are specific to different stakeholders.
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According to some respondents, employers are
focused primarily on costs rather than quality;
are mainly interested in short-term rather than
long-term results; are unwilling to invest in quality; and either do not demand quality or do not
see themselves as being in the business of health
care improvement. Many respondents argued that
consumers do not understand quality; choose
access and cost over quality; do not actively make
decisions about their health care or choice of
providers; and tend to overutilize health services.
Finally, many respondents said that providers are
reluctant to cooperate with efforts to measure
quality; are resistant to dissemination of quality
information; and question the validity and reliability of current quality measures. Several respondents noted that the lack of financial incentives
for providers to furnish higher-quality care is a
major barrier.
Factors Affecting Purchasing Decisions
The expert group was asked to rate the extent to
which various factors currently enter into health
care purchasing decisions. They rated each factor
on a scale of 1 to 9, with 1 being the least influential and 9 being the most influential. In decreasing
order of importance, the factors they cited as influencing purchasing decisions were cost, geographic
coverage of the network, access to care, customer
satisfaction, quality of care provided, and information technology capability (Table 1).
Respondents were asked to rate which
stakeholders in the health care system could drive
improvements in quality and safety. The results are
shown in Table 2.
Participants were also asked about the
respective roles of public and private purchasers of
health care in driving quality. The general consensus was that both parties have potential roles, perhaps even complementary roles, in bringing about
lasting change. Public programs were seen as having the most potential market power; one respondent described such programs as “the 800-pound
gorilla.” However, numerous barriers to using this
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Table 1. Ratings of Factors Cited as Influencing
Purchasing Decisions

Cost
Geographic coverage of the network
Access to care
Customer satisfaction
Quality of care provided
Information technology capability

Mean Rating
(9=highest;
1=lowest)

Standard
Deviation

8.6
7.4
7.1
6.4
4.7
4.4

0.8
1.3
1.3
1.5
2.0
1.9

Source: Goldfarb et al., Office of Health Policy and Clinical Outcomes, Thomas Jefferson University.

Table 2. Ratings of Stakeholders’ Ability to Drive Improvements
in Health Care Quality and Patient Safety

Large employers (>5,000 employees)
Government purchasers
Consumers
Health care providers
Insurers
Midsize employers (500–5,000 employees)
Small employers (<500 employees)

Mean Rating
(9=highest;
1=lowest)

Standard
Deviation

7.3
7.1
6.9
6.8
6.3
5.6
3.5

1.3
1.9
2.0
2.1
1.7
1.9
2.2

Source: Goldfarb et al., Office of Health Policy and Clinical Outcomes, Thomas Jefferson University.

market muscle were noted: public programs have
to justify all purchasing decisions; they cannot
selectively direct patients to providers judged as
offering higher quality; they face higher accountability and political sensitivities; and they cannot be
as innovative or nimble as can private purchasers.
Many of those representing public purchasers commented that they are looking to the
private market to demonstrate the effectiveness of
interventions, which could then be adapted for use
in the public sector. Meanwhile, several private
purchasers suggested that they would like to do
more to influence their local markets but need the
greater visibility and market power that only the
public payers can wield.
Many of the experts argued that midsize and
smaller employers are unlikely to serve as agents of
change. Some respondents noted, however, that
midsize employers with a concentrated local pres-

ence might have greater influence than the large,
national employers with lesser presence in any one
local market. Several respondents also noted that
many of the nationally visible value-based purchasing initiatives currently operating may not be relevant or feasible models for local markets.
Finally, respondents rated the extent to
which they believe value-based purchasing is currently having an impact on quality and safety, as
well as its potential impact in the future. The
results, using the same 1 to 9 scale, are presented in
Table 3. As can be seen, respondents felt that
value-based purchasing is not currently having a
high impact (4.3 mean rating across all respondents), but that its potential impact is significant
(7.8). Employers were the group most likely (5.6)
to feel that value-based purchasing efforts are
already having an impact (p=.002).
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Table 3. Ratings of the Impact of Value-Based Purchasing
on Quality and Safety
CURRENT IMPACT

Constituent Group

POTENTIAL IMPACT

Mean Rating
(9=highest;
1=lowest)

Standard
Deviation

Mean
Rating

Standard
Deviation

4.3
2.9
3.7
5.6
4.6
4.0
3.7

2.0
0.9
2.9
1.8
1.6
2.0
1.4

7.8
5.8
7.5
8.4
7.4
8.2
8.0

1.4
1.9
1.0
0.6
1.4
1.2
1.2

All respondents
Academic researchers
Consulting organizations
Employers
Federal and state government
Insurers and health plans
Support organizations

Source: Goldfarb et al., Office of Health Policy and Clinical Outcomes, Thomas Jefferson University.

CONCLUSIONS AND RECOMMENDATIONS
Following our survey of experts, a national advisory group composed of a subset of respondents
was convened to discuss the implications of the
poll results as well as findings from the published
literature.4 Several conclusions and recommendations emerged from the discussion.
Defining Value-Based Purchasing
The advisory group we convened agreed that
value-based purchasing should be defined broadly
to include the full range of ways purchasers might
influence quality. It should include, for example,
the dissemination of information to consumers
about the quality of care provided by health plans
and physicians. Furthermore, it would also be
helpful to develop a taxonomy of value-based purchasing efforts that matches individual strategies
with the specific issues they are intended to address.
The standards for measuring the outcome of VBP
efforts need further development as well: in addition to measuring their impact on costs and quality
of care, researchers should gauge indirect benefits,
such as employee productivity and retention.
Policy Issues
The VBP movement is predicated on the belief
that purchasers can use their market power to
drive quality improvement. It remains to be seen,
however, whether purchasers can succeed in this

regard and whether other constituencies—consumers, providers, payers—can help effect change.
Public purchasers look to private purchasers to
establish the evidence base for VBP efforts, yet
private purchasers in most regions lack the market
clout to affect health care delivery and financing
systems. Public purchasers, moreover, face political
and legal constraints to experimentation with
VBP activities.
One of the keys to improving the quality of
health care is to realign financial incentives.
According to advisory group members, purchasers
could play a major role in shaping payment systems that emphasize prevention and well care, and
that reward payers and providers for delivering
quality. Having uniform performance measures also
is critical. However, at present, few exist, and those
that do, such as the Health Plan Employer Data
and Information Set, have been criticized for being
focused largely on processes rather than outcomes,
and being of limited use in guiding development
of specific quality improvement strategies.
Another impediment to the use of VBP is
the lack of a clearly established relationship between
cost and quality in health care. Many VBP efforts
are based on the assumption that a business case
for quality does indeed exist, and that the return
on investment in VBP efforts can and should be
demonstrated. However, the business case for quality is largely theoretical and has yet to be proven
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through empirical observation. Some believe that
quality may ultimately cost more, and that the focus
of VBP should be on “doing the right thing”—
ensuring the best possible health care for patients—
rather than on controlling long-term spending.
Role of the Employer
Employers engage in VBP activities for a variety of
reasons. Some do so out of the belief that they
have not been getting value for their money, others
out of a sense of duty to provide their employees
with good-quality care. Some employers are convinced that VBP activities will lead to direct savings
or to indirect benefits such as increased productivity.
So far, large employers with a national presence and regional purchasing coalitions have been
the driving forces of the VBP movement, although
smaller employers could potentially play a greater
role in driving quality within their own markets.
Coalitions, in particular, offer several advantages. In
addition to greater financial resources, they enjoy a
heightened market presence, more extensive and
reliable performance data, and a forum for sharing
experiences and ideas. In order to foster the development of purchasing coalitions in local markets, a
better understanding of their costs and benefits is
needed. Answers are needed to a number of questions: Why are employers in coalitions and what
do they get out of it? How do coalitions work?
Who are the leaders and who rides the coattails?
How can a group of employers get started? How
do coalitions support each other?
The fact remains, however, that few employers nationwide have VBP programs in place.
Although little is known about why more of them
do not, several possible explanations have been
advanced, including employers’ unwillingness to
become involved in the health care industry, lack
of market power or financial resources, and the
dearth of evidence showing that VBP affects costs
and quality. If VBP were proven to be effective in
raising levels of quality and safety, what would it
take to turn more employers into participants?
In the meantime, escalating health care costs
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are likely to have an immediate effect on the VBP
movement. Some employers are already capping
their financial commitments to health care through
defined contribution plans and thus may have less
of an interest in quality. Employers in the early
stages of VBP may shift their efforts to cost control. If employers are to be expected to continue
investing in quality and safety, establishing a business case for quality will be essential.
Role of the Consumer
The experts convened were in general agreement
that consumers have the potential to drive quality
improvement. While some argued that consumers
do not understand quality, others claimed that consumers are savvy about their health care choices.
Many had questions, though, about whether and
how to encourage the “end-user” to hold
providers accountable for the care they provide.
Most concurred that consumers will pay more
attention to quality considerations as they become
more exposed to out-of-pocket costs—provided
they have access to comprehensive, and comprehensible, information on health care providers.
Evaluation of Value-Based Purchasing
Activities
The growth of the VBP movement depends to a
large extent on evidence of its impact on quality,
safety, and costs. Such efforts, however, may take
years to produce results, and some of the evaluations currently under way—such as one of the
Leapfrog Group’s program that is being funded by
the Robert Wood Johnson Foundation and the
Agency for Healthcare Research and Quality—
may be premature. Despite such concerns, there
was a general interest expressed in taking a closer
look at the VBP initiatives that have reported success. Detailed case studies were mentioned as an
important way to document the experiences of
those involved in VBP, even if the experiences of
national and large employers may not always be
applicable at the local level. Case studies, which
could serve as the basis for an eventual purchaser
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Group on Health, Reducing the Costs of Poor Quality
Health Care through Responsible Purchasing Leadership.
2002 Report. Available at http://www.mbgh.org.
Accessed December 22, 2002; Meyer, J., Rybowski,
L., Eichler, R, Theory and Reality of Value-Based
Purchasing: Lessons from the Pioneers. Agency for Health
Care Policy and Research. Pub. No. 98-0004, 1997.

“toolkit,” would help generate answers to such
important questions as:
●

●

●

●

●

●

What is working and what is not? What are the
criteria for determining if something is working?
How much time does it take to produce results?
What infrastructure is needed to create and
maintain VBP efforts?

We are currently conducting a more expansive survey
of the purchasing activities of midsize and large
employers. The project is being supported by The
Commonwealth Fund.
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The consortia named were: The Alliance; Buyers
Health Care Action Group; Central Florida Health
Care Coalition; The Leapfrog Group; Lehigh Valley
Business Conference on Health Care; and Pacific
Business Group on Health. The individual organizations named were: Dell Computers; Ford Motor Co.;
General Electric; General Motors, Honeywell; IBM;
Kaiser Permanente; State of New York; Union Pacific;
U.S. Air Force;Verizon; and Xerox.
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Advisory group members included: Diane Bechel,
Dr.P.H., Six SigmaHC Blackbelt, Ford Motor
Company; Robert Berenson, M.D., Senior
Advisor, Academy for Health Services Research &
Health Policy; Becky J. Cherney, President & CEO,
Central Florida Health Care Coalition; Charles M.
Cutler, M.D., Chief Medical Officer, American
Association of Health Plans; Catherine Gallagher,
President, Lehigh Valley Business Conference on
Health Care; Christopher Gorton, M.D., Chief
Medical Officer, Office of the Medical Director,
Pennsylvania Department of Public Welfare; Maggie
Mellen, M.A., Senior Vice President of Healthcare,
Board of Pensions of The Presbyterian Church
(USA); James Mortimer, President, Midwest
Business Group on Health; Lee N. Newcomer,
M.D., Executive Vice President and Chief Medical
Officer,Vivius, Inc.; Carolyn Pare, Chief Executive
Officer, Buyers Health Care Action Group; Jeffrey
Rice, M.D., J.D., Executive Vice President,
American Healthways; Gerald Shea, Assistant to the
President for Government Affairs, AFL-CIO; David
M. Spratt, D.O., Vice President and Medical
Director, Crown Cork and Seal; Donald
Steinwachs, Ph.D., Professor and Chair, Johns
Hopkins University, Bloomberg School of Public
Health; and John P. Sullivan, Vice President,
Administration, Thomas Jefferson University.

What impacts did the VBP activities have on
insurers, providers, and consumers?

SUMMARY
Efforts on the part of several large employers and
business coalitions are beginning to demonstrate
health care purchasers’ commitment to quality. The
Leapfrog Group, for example, has developed a small
number of quality-improvement expectations for
inpatient providers and plans to continue broadening the scope of its initiatives over time. However,
for this and other nationally visible initiatives, it
appears that many purchasers are either choosing
not to participate, or are passive participants. As
one of the respondents to our survey commented,
“The pioneers have blazed the path, but not many
have followed.”
This issue brief has highlighted obstacles to
growth of the value-based purchasing movement,
including data limitations, measurement concerns,
administrative and financial barriers, and stakeholder behaviors and attitudes. Future research
should focus on increasing our understanding of
how these barriers can be overcome and how the
purchaser’s role in driving quality improvement
can be fostered.
NOTES
1

2

Which models work in different markets?
What barriers to VBP were encountered and
how were they addressed?

See Vittorio Maio, Neil I. Goldfarb, Chureen Carter,
and David B. Nash, Value-Based Purchasing: A Review of
the Literature. The Commonwealth Fund, May 2003.
Available at http://www.cmwf.org; Midwest Business
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METHODOLOGY
In the spring of 2002, a telephone survey was conducted with value-based purchasing experts identified
through a literature review, Internet search, and preliminary conversations with selected thought leaders identified through literature review. Separate questionnaires were developed for each of the six constituent groups
(academic researchers, consulting organizations, employers, federal and state government, insurers and health
plans, and support organizations), although the majority of questions were identical. The primary qualitative,
open-ended questions included:
●

What is your role in value-based purchasing activities?

●

Have you seen any successful models of value-based purchasing? If so, where?

●

What factors make them successful?

●

What do you see as the key barriers to value-based purchasing?

All quantitatively scored questions were identical across all versions of the questionnaire. Respondents rated
factors on a one to nine scale, with one being lowest and nine being highest. The questions included:
●

●

●

To what extent are each of the following factors entering into purchasing decisions: cost, access, information technology, geographic coverage, customer satisfaction, and quality of care?
To what extent is value-based purchasing currently affecting quality of care, and to what extent does it have
the potential to affect it?
To what extent can each of the following stakeholders drive improvements in quality: consumers, providers,
government purchasers, insurers, and small, midsize, and large employers?

